| New directions in allergic diseases: mechanism-based anti-inflammatory therapies. | |
| | |
MedLine Citation:
|
PMID: 10887299 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Advances in our understanding of allergic inflammation have led to the development of several novel anti-inflammatory drugs that target specific aspects of the inflammatory process. These treatments are based on improvements in existing therapies or on a better understanding of the cellular and molecular mechanisms involved in atopic diseases. Although most attention has been focused on asthma, treatments that inhibit the atopic disease process would have application to all atopic diseases, which often coincide. Specific agents that are now in development for the treatment of allergic inflammation include inhibitors of eosinophilic inflammation (eg, anti-IL-5, CCR3 antagonists, and very late antigen 4 inhibitors), drugs that may inhibit allergen presentation, and inhibitors of T(H)2 cells. More general anti-inflammatory approaches include novel cortico-steroids, phosphodiesterase inhibitors, and mitogen-activated protein kinase inhibitors. Most of the new therapies in development are aimed at inhibiting or suppressing components of the allergic inflammatory response, but in the future, there are possibilities for development of preventive and curative treatments. |
| | |
Authors:
|
P J Barnes |
Related Documents
:
|
17989979 - Defining a role for ambient tlr ligand exposures in the genesis and prevention of aller... 11321129 - Prevalence and relationship between allergic diseases and infectious diseases. 16461999 - A specific ccr3 chemokine receptor antagonist inhibits both early and late phase allerg... 8875759 - Onset of graves' thyrotoxicosis after an attack of allergic rhinitis. 11486439 - Nasal inflammation and anti-inflammatory treatment. semantics or clinical reality. 15224629 - Allergic rhinitis: aetiology, predisposing and risk factors. 3983349 - Alexithymia and chronic respiratory disease. a review of current research. 14691999 - Rapid prenatal diagnosis of x-linked chronic granulomatous disease using a denaturing h... 10878819 - Is there a cause-and-effect relationship between alpha-synuclein fibrillization and par... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: The Journal of allergy and clinical immunology Volume: 106 ISSN: 0091-6749 ISO Abbreviation: J. Allergy Clin. Immunol. Publication Date: 2000 Jul |
Date Detail:
|
Created Date: 2000-08-09 Completed Date: 2000-08-09 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 1275002 Medline TA: J Allergy Clin Immunol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 5-16 Citation Subset: AIM; IM |
Affiliation:
|
Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College, London. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenal Cortex Hormones
/
therapeutic use Anti-Inflammatory Agents / therapeutic use* Cytokines Gene Therapy Humans Hypersensitivity / drug therapy*, prevention & control Immunosuppressive Agents / therapeutic use Models, Biological |
| Chemical | |
Reg. No./Substance:
|
0/Adrenal Cortex Hormones; 0/Anti-Inflammatory Agents; 0/Cytokines; 0/Immunosuppressive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cytotoxic action of conjugates of alpha-fetoprotein and epidermal growth factor with photoheme, chlo...
Next Document: Monitoring the patient with asthma: an evidence-based approach.